^
    10ms
    Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies (clinicaltrials.gov)
    P1, N=60, Recruiting, BioEclipse Therapeutics | N=24 --> 60 | Trial completion date: Mar 2025 --> Oct 2026 | Trial primary completion date: Oct 2024 --> Aug 2025
    Enrollment change • Trial completion date • Trial primary completion date • Combination therapy • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
    |
    Keytruda (pembrolizumab) • cyclophosphamide • fludarabine IV • CRX100
    over2years
    Study of CRX100 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=24, Recruiting, BioEclipse Therapeutics | Trial completion date: May 2022 --> Mar 2025 | Trial primary completion date: May 2022 --> Oct 2024
    Trial completion date • Trial primary completion date
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
    |
    CRX100
    4years
    Study of CRX100 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=24, Recruiting, BioEclipse Therapeutics | Not yet recruiting --> Recruiting
    Clinical • Enrollment open
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
    |
    CRX100
    4years
    Study of CRX100 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=24, Not yet recruiting, BioEclipse Therapeutics | Initiation date: Jun 2020 --> Oct 2020
    Clinical • Trial initiation date
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
    |
    CRX100
    almost5years
    Study of CRX100 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=24, Not yet recruiting, BioEclipse Therapeutics
    Clinical • New P1 trial
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
    |
    CRX100